ArticleBMC medical research methodology2025
Computationally efficient Bayesian inference for semi-parametric joint models of competing risks survival and skewed longitudinal data using integrated nested Laplace approximation.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundJoint modeling is widely used in medical research to properly analyze longitudinal biomarkers and survival outcomes simultaneously and to guide appropriate interventions in public health. However, such models become increasingly complex and computationally intensive when accounting for multiple features of these outcomes. The need for computationally efficient methods in joint modeling of competing risks survival outcomes and longitudinal biomarkers is particularly critical in clinical and epidemiological settings, where prompt decision-making is essential. Moreover, there is very little literature on joint modeling of competing risks survival and skewed longitudinal data using Integrated Nested Laplace Approximations (INLA), despite its growing popularity in Bayesian inference. This paper presents a computationally efficient inference approach for modeling competing risks survival and skewed longitudinal data using INLA.
methodsWe propose cause-specific competing risks joint models with a semi-parametric mixed-effects longitudinal submodel and second-order random walk baseline hazards. The proposed models are reformulated as latent Gaussian models to enable efficient Bayesian inference using INLA. The INLA approach and its R packages are also presented. Various smoothing spline functions, distributions, and association structures were evaluated for both approaches. The INLAjoint and R2WinBUGS R packages were employed for the INLA and Markov-Chain Monte-Carlo (MCMC) approaches, respectively, to approximate the posterior marginals of the proposed joint models. Model comparisons and performance evaluations were performed using the deviance information criterion, relative bias, coverage probability, and root mean squared error.
resultsWe evaluated the computational efficiency and estimation performance of the INLA and MCMC approaches using real-world chronic kidney disease (CKD) follow-up data and an extensive confirmatory simulation study. We also conducted several model comparisons by considering different specifications related to smoothing spline approximations, non-Gaussian (skewed) distributions, and association structures to identify the best-fitting models for the CKD data and ensure robust statistical inference.
conclusionThe application and simulation results revealed that both approaches provide accurate statistical estimation and inference. However, INLA significantly reduces the computational burden of the proposed joint models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.